IceCure Medical Ltd Stock TEL AVIV STOCK EXCHANGE
Stocks
ICCM
IL0011224156
Advanced Medical Equipment & Technology
| Market Cap | 18.37M 5.5B 16.06M 14.74M 13.76M 26.08M 1.75B 26.46M 177M 68.84M 859M 68.95M 67.45M 2.96B | P/E 2026 * |
-0.95x | P/E 2027 * | -1.38x |
|---|---|---|---|---|---|
| Enterprise Value | 18.37M 5.5B 16.06M 14.74M 13.76M 26.08M 1.75B 26.46M 177M 68.84M 859M 68.95M 67.45M 2.96B | EV / Sales 2026 * |
2.88x | EV / Sales 2027 * | 1.46x |
| Free-Float |
60.06% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IceCure Medical Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Eyal Shamir
CEO | Chief Executive Officer | 65 | 2016-08-31 |
Meir Peleg
DFI | Director of Finance/CFO | 50 | 2026-05-16 |
Shay Levav
COO | Chief Operating Officer | 49 | 2025-11-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Eyal Shamir
BRD | Director/Board Member | 65 | 2017-12-04 |
| Chairman | 62 | 2017-12-04 | |
Sharon Levita
BRD | Director/Board Member | 57 | 2019-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -6.22% | - | - | 18.37M | |
| +1.97% | +2.03% | +21.92% | +0.83% | 195B | |
| +5.87% | +5.27% | -21.76% | +26.78% | 151B | |
| +2.17% | +0.89% | -2.59% | -16.42% | 140B | |
| +4.83% | +2.06% | -56.73% | -15.69% | 67.09B | |
| +2.59% | +3.95% | +22.89% | +3.15% | 54.34B | |
| +0.03% | +2.19% | -25.48% | -31.00% | 44.63B | |
| +0.31% | +1.30% | +8.30% | +43.25% | 37.24B | |
| -2.02% | -3.91% | +7.67% | +9.53% | 36.91B | |
| +4.24% | +4.66% | -18.42% | -2.34% | 30.24B | |
| Average | +2.00% | +2.74% | -7.13% | +2.01% | 83.99B | |
| Weighted average by Cap. | +2.78% | +3.44% | -4.03% | +2.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.37M 1.91B 5.57M 5.11M 4.77M 9.04M 606M 9.18M 61.43M 23.88M 298M 23.91M 23.39M 1.03B | 12.55M 3.76B 10.97M 10.07M 9.4M 17.81M 1.19B 18.08M 121M 47.03M 587M 47.1M 46.07M 2.02B |
| Net income | -16.63M -4.98B -14.54M -13.35M -12.46M -23.61M -1.58B -23.96M -160M -62.33M -777M -62.43M -61.07M -2.68B | -14.06M -4.21B -12.29M -11.28M -10.53M -19.96M -1.34B -20.25M -136M -52.69M -657M -52.77M -51.62M -2.27B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
